Journal article 136 views
In vitro efficacy of imipenem-relebactam and cefepime-AAI101 against a global collection of ESBL-positive and carbapenemase-producing Enterobacteriaceae
Lucas Tselepis 
,
Gareth W. Langley ,
Ali F. Aboklaish,
Emma Widlake,
Dana E. Jackson,
Timothy R. Walsh,
Chris J. Schofield,
Jürgen Brem,
Jon Tyrrell
,
Gareth W. Langley ,
Ali F. Aboklaish,
Emma Widlake,
Dana E. Jackson,
Timothy R. Walsh,
Chris J. Schofield,
Jürgen Brem,
Jon Tyrrell
International Journal of Antimicrobial Agents, Volume: 56, Issue: 1, Start page: 105925
Swansea University Author:
Jon Tyrrell
Full text not available from this repository: check for access using links below.
DOI (Published version): 10.1016/j.ijantimicag.2020.105925
Abstract
In vitro efficacy of imipenem-relebactam and cefepime-AAI101 against a global collection of ESBL-positive and carbapenemase-producing Enterobacteriaceae
| Published in: | International Journal of Antimicrobial Agents |
|---|---|
| ISSN: | 0924-8579 |
| Published: |
Elsevier BV
2020
|
| Online Access: |
Check full text
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa70431 |
| first_indexed |
2025-09-21T22:01:41Z |
|---|---|
| last_indexed |
2025-10-17T09:30:56Z |
| id |
cronfa70431 |
| recordtype |
SURis |
| fullrecord |
<?xml version="1.0"?><rfc1807><datestamp>2025-10-16T13:46:45.9726802</datestamp><bib-version>v2</bib-version><id>70431</id><entry>2025-09-21</entry><title>In vitro efficacy of imipenem-relebactam and cefepime-AAI101 against a global collection of ESBL-positive and carbapenemase-producing Enterobacteriaceae</title><swanseaauthors><author><sid>ad510c73555adf718387af219e235a6e</sid><ORCID>0000-0001-8565-2590</ORCID><firstname>Jon</firstname><surname>Tyrrell</surname><name>Jon Tyrrell</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2025-09-21</date><deptcode>MEDS</deptcode><abstract/><type>Journal Article</type><journal>International Journal of Antimicrobial Agents</journal><volume>56</volume><journalNumber>1</journalNumber><paginationStart>105925</paginationStart><paginationEnd/><publisher>Elsevier BV</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>0924-8579</issnPrint><issnElectronic/><keywords/><publishedDay>1</publishedDay><publishedMonth>7</publishedMonth><publishedYear>2020</publishedYear><publishedDate>2020-07-01</publishedDate><doi>10.1016/j.ijantimicag.2020.105925</doi><url/><notes>Short Communication</notes><college>COLLEGE NANME</college><department>Medical School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>MEDS</DepartmentCode><institution>Swansea University</institution><apcterm/><funders>GWL, JB and CJS thank Wellcome Trust, the Medical Research Council, the Biotechnology and Biological Research Council (BB/S50676X/1), the Innovative Medicines Initiative (European Lead Factory and ENABLE components), for funding work on antibiotics, MBL fold enzymes and β-lactamase inhibitors. JMT, AA and EW would also like to thank ENABLE for funding antimicrobial-related research.</funders><projectreference/><lastEdited>2025-10-16T13:46:45.9726802</lastEdited><Created>2025-09-21T18:15:29.2510010</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Biomedical Science</level></path><authors><author><firstname>Lucas</firstname><surname>Tselepis</surname><orcid>0000-0002-5476-3949</orcid><order>1</order></author><author><firstname>Gareth W.</firstname><surname>Langley</surname><orcid>0000-0003-0875-3712</orcid><order>2</order></author><author><firstname>Ali F.</firstname><surname>Aboklaish</surname><order>3</order></author><author><firstname>Emma</firstname><surname>Widlake</surname><order>4</order></author><author><firstname>Dana E.</firstname><surname>Jackson</surname><order>5</order></author><author><firstname>Timothy R.</firstname><surname>Walsh</surname><order>6</order></author><author><firstname>Chris J.</firstname><surname>Schofield</surname><order>7</order></author><author><firstname>Jürgen</firstname><surname>Brem</surname><order>8</order></author><author><firstname>Jon</firstname><surname>Tyrrell</surname><orcid>0000-0001-8565-2590</orcid><order>9</order></author></authors><documents/><OutputDurs/></rfc1807> |
| spelling |
2025-10-16T13:46:45.9726802 v2 70431 2025-09-21 In vitro efficacy of imipenem-relebactam and cefepime-AAI101 against a global collection of ESBL-positive and carbapenemase-producing Enterobacteriaceae ad510c73555adf718387af219e235a6e 0000-0001-8565-2590 Jon Tyrrell Jon Tyrrell true false 2025-09-21 MEDS Journal Article International Journal of Antimicrobial Agents 56 1 105925 Elsevier BV 0924-8579 1 7 2020 2020-07-01 10.1016/j.ijantimicag.2020.105925 Short Communication COLLEGE NANME Medical School COLLEGE CODE MEDS Swansea University GWL, JB and CJS thank Wellcome Trust, the Medical Research Council, the Biotechnology and Biological Research Council (BB/S50676X/1), the Innovative Medicines Initiative (European Lead Factory and ENABLE components), for funding work on antibiotics, MBL fold enzymes and β-lactamase inhibitors. JMT, AA and EW would also like to thank ENABLE for funding antimicrobial-related research. 2025-10-16T13:46:45.9726802 2025-09-21T18:15:29.2510010 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Biomedical Science Lucas Tselepis 0000-0002-5476-3949 1 Gareth W. Langley 0000-0003-0875-3712 2 Ali F. Aboklaish 3 Emma Widlake 4 Dana E. Jackson 5 Timothy R. Walsh 6 Chris J. Schofield 7 Jürgen Brem 8 Jon Tyrrell 0000-0001-8565-2590 9 |
| title |
In vitro efficacy of imipenem-relebactam and cefepime-AAI101 against a global collection of ESBL-positive and carbapenemase-producing Enterobacteriaceae |
| spellingShingle |
In vitro efficacy of imipenem-relebactam and cefepime-AAI101 against a global collection of ESBL-positive and carbapenemase-producing Enterobacteriaceae Jon Tyrrell |
| title_short |
In vitro efficacy of imipenem-relebactam and cefepime-AAI101 against a global collection of ESBL-positive and carbapenemase-producing Enterobacteriaceae |
| title_full |
In vitro efficacy of imipenem-relebactam and cefepime-AAI101 against a global collection of ESBL-positive and carbapenemase-producing Enterobacteriaceae |
| title_fullStr |
In vitro efficacy of imipenem-relebactam and cefepime-AAI101 against a global collection of ESBL-positive and carbapenemase-producing Enterobacteriaceae |
| title_full_unstemmed |
In vitro efficacy of imipenem-relebactam and cefepime-AAI101 against a global collection of ESBL-positive and carbapenemase-producing Enterobacteriaceae |
| title_sort |
In vitro efficacy of imipenem-relebactam and cefepime-AAI101 against a global collection of ESBL-positive and carbapenemase-producing Enterobacteriaceae |
| author_id_str_mv |
ad510c73555adf718387af219e235a6e |
| author_id_fullname_str_mv |
ad510c73555adf718387af219e235a6e_***_Jon Tyrrell |
| author |
Jon Tyrrell |
| author2 |
Lucas Tselepis Gareth W. Langley Ali F. Aboklaish Emma Widlake Dana E. Jackson Timothy R. Walsh Chris J. Schofield Jürgen Brem Jon Tyrrell |
| format |
Journal article |
| container_title |
International Journal of Antimicrobial Agents |
| container_volume |
56 |
| container_issue |
1 |
| container_start_page |
105925 |
| publishDate |
2020 |
| institution |
Swansea University |
| issn |
0924-8579 |
| doi_str_mv |
10.1016/j.ijantimicag.2020.105925 |
| publisher |
Elsevier BV |
| college_str |
Faculty of Medicine, Health and Life Sciences |
| hierarchytype |
|
| hierarchy_top_id |
facultyofmedicinehealthandlifesciences |
| hierarchy_top_title |
Faculty of Medicine, Health and Life Sciences |
| hierarchy_parent_id |
facultyofmedicinehealthandlifesciences |
| hierarchy_parent_title |
Faculty of Medicine, Health and Life Sciences |
| department_str |
Swansea University Medical School - Biomedical Science{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Biomedical Science |
| document_store_str |
0 |
| active_str |
0 |
| published_date |
2020-07-01T05:30:52Z |
| _version_ |
1851098034255953920 |
| score |
11.089386 |